Department of Medicine

The HSR Center supports health services research studies that aim to enhance, improve, and revise healthcare systems so that they can perform at the highest quality, value, and deliver the best patient outcomes. The program aims to not only have an impact on Emory University and Emory Healthcare's missions, but to also create a paradigm for clinical/research institutions nationwide.

HSR Seminar Series

HSRC Seminar Series: Featured Speaker

Inequitable Access to Live Donor Kidney Transplant for Patients from Racialized Communities in Canada – Potential Causes and Possible Solutions

Wednesday, August 24, 2022, 2:00 PM – 3:00 PM ET


Istvan Mucsi, MD, PhD
Transplant Nephrologist and Clinician Investigator, Amjera Transplant Center and Division of Nephrology, University Health Network (UHN) Toronto
Associate Professor of Medicine, University of Toronto

Dr. Istvan Mucsi studies potentially modifiable factors underlying inequities in the utilization of live donor kidney transplant among patients from racialized communities. This work is done in partnership with African, Caribbean, Black, Chinese, and South Asian community organizations, patient partners, and professionals. He employs both quantitative and qualitative research methodologies in these projects, which inform the co-development of educational resources and clinical pathways supporting these communities as they explore treatment options for kidney failure. He leads the education pillar of the "Enabling Access to Kidney Transplantation" provincial (Ontario) strategy sponsored by the Ontario Renal Network. Dr. Musci also studies the physical and emotional symptoms that are important determinants of quality of life of patients with kidney disease and solid organ transplant, and is validating tools developed by the Patient Reported Outcomes Measurement Information System (PROMIS) so that they can be integrated into the clinical workflow and advance clinical response pathways for better patient centered care. He is a member of the UHN Transplant Outcome Research Group and the UHN PROM/PREM Clinical Advisory group, an expert advisor of the "Data innovation platform" of the Canadian Donation and Transplant Research Program and the European Cooperation in Science and Technology, and the Hungarian national representative in the PROMIS Health Organization International Network.

Register for the webinar here

Other Events & Opportunities

2022 PCORI Annual Meeting. The PCORI Annual Meeting brings together members of the healthcare community, including researchers, patients, caregivers, clinicians, insurers, health system representatives, and other stakeholders. The event serves as a report to the nation on PCORI's progress in funding initiatives to determine which care approaches work best, for whom, and under what circumstances. October 26-October 7, 2022, Arlington, VA, plus online. Check for meeting updates here.

Emory Department of Medicine Annual Research Day. This event brings together researchers from all divisions and provides an opportunity to share exciting new findings, facilitate scientific exchange, and identify potential new collaborations. The keynote speaker will be E. Dale Abel, MD, PhD, William S. Adams Distinguished Professor of Medicine and Chair and Executive Medical Director, Department of Medicine, David Geffen School of Medicine. October 27, 2022, 8:00 AM – 5:00 PM, Emory Student Center. Visit the Emory DOM website for updates.

Faculty Spotlight:

Raymond Lynch and Neal Dickert named new associate directors of the Health Services Research Center

Transplant surgeon Raymond Lynch, MD, and cardiologist Neal Dickert, MD, PhD, have been named associate directors of the Health Services Research Center (HSRC). They will join founding director Rachel Patzer, PhD, MPH, and the rest of HSRC's leadership team in advancing its mission of increasing healthcare access, quality, value, and outcomes for all patients and populations through scientific inquiry and innovative solutions.

Dr. Lynch joins the HSRC from the Division of Transplantation of the Department of Surgery, where he specializes in liver and kidney transplantation. His health services research interests include resource utilization and outcomes analysis in transplantation, and he is highly dedicated to improving the distribution of grafts to patients with organ failure. Dr. Lynch's work has been used as a basis for new government metrics on deceased donor procurement, and his research and advocacy efforts have been instrumental in bringing focus to barriers in access to transplantation for patients in poor, rural, and medically underserved populations.

Dr. Dickert is a member of the Division of Cardiology of the Department of Medicine. His clinical work focuses on cardiac intensive care, while his research is concentrated on ethics and decision science, particularly the ethical aspects of clinical research. His current research projects are studying the impact of disclosure of out-of-pocket cost information on decision-making, evaluating the impact of recent policy-mandated implementation of shared decision-making tools, and developing and examining innovative approaches to informed consent. As director of the Georgia CTSA Recruitment Center, Dr. Dickert also works to advance integration of clinical research and clinical care across the Emory community.

"We look forward to collaborating with these impressive investigators as we continue the next round of strategic planning for the HSRC," says Dr. Patzer.

Raymond Lynch and Neal Dickert

HSR-Related News

Jessica Harding, PhD, will apply the HSRC Pilot Award to identifying factors associated with gender disparities in access to transplantation among patients with end-stage kidney disease. Preliminary data suggests that disparities occur early in the steps to receive a transplant for women compared to men, and Dr. Harding hopes to define the magnitude of this imbalance.

After analyzing data from three southeastern states, a study led by Rachel Patzer, PhD, MPH, found that following the implementation of the national kidney allocation system (KAS) in 2014, access to early steps in the kidney transplant process increased for some patients.

Anant Madabhushi, PhD, a global leader in developing artificial intelligence to improve outcomes for individuals with cancer and other diseases, will join Emory School of Medicine in July 2022 as part of the university's growing research community focused on advancing AI to serve humanity.

The U.S. Food and Drug Administration has announced that molnupiravir, an oral antiviral drug invented by scientists at Emory University, has received Emergency Use Authorization (EUA) for treatment of COVID-19. Emory has discovered and advanced some of the world’s most important and valuable drugs such as belatacept for kidney transplants, Obizur for hemophilia, and Emtriva for HIV.

Recent Emory HSR Publications

Contact Us

Rachel Patzer, PhD
Director, Emory Health Services Research Center

Larissa Teunis, MPA
Program Manager, Emory Health Services Research Center

HSRC Email
Mailing Address:
Health Services Research Center
Emory University School of Medicine
101 Woodruff Circle, 5034 WMB
Mailstop 1930 / 001 / AD
Atlanta, GA 30322